Status:
COMPLETED
Postprandial Lipid Metabolism in Patients With Hypertriglyceridemia and Normo-lipidemic Controls: Medium Chain Fatty Acids (MCT) in Comparison to Long-chain, Saturated Fatty Acids (SFA) and Mono-unsaturated Fatty Acids (MUFA)
Lead Sponsor:
Ludwig-Maximilians - University of Munich
Conditions:
Hypertriglyceridemia
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Postprandial lipid metabolism will be evaluated in patients with hypertriglyceridemia and normo-lipidemic controls; different fats will be used (saturated fatty acids, mon-unsaturated fatty acids and ...
Eligibility Criteria
Inclusion
- hypertriglyceridemia (150 mg/dl-900 mg/dl)
Exclusion
- Lipid lowering drugs or indication for Lipid lowering drugs
- LDL-cholesterol \> 190 mg/dl
- Diabetes mellitus
Key Trial Info
Start Date :
February 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2021
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT03846908
Start Date
February 1 2019
End Date
March 31 2021
Last Update
September 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Munich
Munich, Germany, 81377